Subjects | 284 | 284 | | 135 | 150 | |
Cough# | 92 (32.4) | 94 (33.0) | 0.929 | 34 (25.2) | 60 (40.0) | 0.008 |
Haemoptysis# | 11 (3.9) | 21 (7.4) | 0.1 | 11 (8.1) | 10 (6.7) | 0.657 |
Fatigue# | 138 (48.6) | 89 (31.2) | <0.001 | 40 (29.6) | 49 (32.7) | 0.610 |
Fevers# | 74 (26.1) | 26 (9.1) | <0.001 | 12 (8.9) | 14 (9.3) | 1 |
Severe dyspnoea# | 57 (20.1) | 3 (1.1) | <0.001 | 3 (2.2) | 0 | 0.105 |
Night sweats# | 98 (34.5) | 51 (17.9) | <0.001 | 22 (16.3) | 29 (19.3) | 0.539 |
Chest pain# | 163 (57.4) | 76 (26.7) | <0.001 | 31 (23.0) | 45 (30.0) | 0.227 |
Cavitation | 46 (16.2) | 50 (17.5) | 0.737 | 20 (14.8) | 30 (20.0) | 0.277 |
New cavitation | | 4 (1.4) | | 3 (2.2) | 1 (0.7) | 0.346 |
Deterioration of pre-existing cavitation | | 3 (1.1) | | 3 (2.2) | 0 | 0.104 |
All progressive cavitation | | 7 (2.5) | | 6 (4.4) | 1 (0.7) | 0.055 |
Paracavitary fibrosis | 24 (8.5) | 36 (12.6) | 0.133 | 15 (11.1) | 21 (14.0) | 0.481 |
New paracavitary fibrosis | | 12 (4.2) | | 4 (3.0) | 8 (5.3) | 0.387 |
Deterioration of pre-existing paracavitary fibrosis | | 6 (2.1) | | 3 (2.2) | 3 (2.0) | 1 |
All progressive paracavitary fibrosis | | 18 (6.3) | | 7 (5.2) | 11 (7.3) | 0.627 |
Pleural thickening | 44 (15.5) | 50 (17.5) | 0.573 | 20 (14.8) | 30 (20.0) | 0.277 |
New pleural thickening | | 6 (2.1) | | 3 (2.2) | 3 (2.0) | 1 |
Deterioration of pre-existing pleural thickening | | 10 (3.5) | | 3 (2.2) | 7 (4.7) | 0.343 |
All progressive pleural thickening | | 16 (5.6) | | 6 (4.4) | 10 (6.7) | 0.453 |
Fungal ball | 9 (3.2) | 13 (4.6) | 0.515 | 4 (3.0) | 9 (6.0) | 0.265 |
New fungal ball | | 4 (1.4) | | 2 (1.5) | 2 (1.3) | 1 |
Deterioration of pre-existing fungal ball | | 3 (1.1) | | 1 (0.7) | 2 (1.3) | 1 |
All progressive fungal ball | | 7 (2.5) | | 3 (2.2) | 4 (2.7) | 1 |
Any radiological progression | | 34 (11.9) | | 15 (11.1) | 19 (12.7) | 0.718 |
Aspergillus IgG >20 mg·L−1 | 15 (5.3) | 28 (9.8) | 0.056 | 9 (6.7) | 19 (12.7) | 0.111 |